ARCHIVE

• Toyama Chemical: Sales Up 47.0% to \24,746 Mil.
  May 23, 2005

• Takeda: Consolidated Sales Top \1,100 Bil.
  May 23, 2005

• Kyowa Hakko to Build "Base for Future Growth" Over Next 3 Years
  May 23, 2005

• Overseas Sales Drive Eiken's Business
  May 23, 2005

• JAMS, JACCC to Reconcile Cancer Specialist Systems of JSCO and JSMO
  May 23, 2005

• NEW PRODUCTS
  May 23, 2005

• Sankyo: Mevalotin Patent Expiration Hits Business
  May 23, 2005

• R&D NEWS IN BRIEF
  May 23, 2005

• MPC Aims at Becoming Global Pharma through Holding Company
  May 23, 2005

• Spiriva Can Cut COPD Treatment Cost by ¥59 Bil. a Year
  May 23, 2005

• Discovering 2 to 3 New Drug Candidates a Year "Achievable": Tanabe Seiyaku
  May 23, 2005

• PMDA to Restart Receiving Applications for Clinical Trial Consultation
  May 23, 2005

• Santen: Domestic Market Spurs Growth in Sales
  May 23, 2005

• PMDA Expediting the Review Process
  May 23, 2005

• Kaken: Sales Up 3% to \74,922 Mil.
  May 23, 2005

• Chuikyo Recommends Approval of Shionogi's Doripenem
  May 23, 2005

• Taisho: Self-medication Sales Down 2.5% to \183,416 Mil.
  May 23, 2005

• Central, Local Gov't Must Cooperate Closely to Effectively Implement Amended PAL
  May 23, 2005

• Kyorin: Sales Up 1.9% to \66,296 Mil.
  May 23, 2005

• Approval Standards Established for 3 Dietary Fibers, 6 Oligosaccharides
  May 23, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 465
• 466
• 467
• 468
• 469
• 470
• 471
• 472
• 473
• …
• Next ›
• 最終 »